David T. Yeung
Affiliations: | National Institutes of Health, Bethesda, MD |
Area:
Cholinergic, anticholinesterase, bioscavenger, paraoxonaseGoogle:
"David Yeung"Mean distance: 26716.5
Parents
Sign in to add mentor| Douglas M. Cerasoli | grad student | 2004-2007 | U.S. Army Medical Research Institute of Chemical Defense |
| Averell Gnatt | grad student | 2004-2007 | University of Maryland Medical School |
| David E. Lenz | grad student | 2004-2007 | U.S. Army Medical Research Institute of Chemical Defense |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Araj H, Tseng H, Yeung DT. (2022) Supporting discovery and development of medical countermeasures for chemical injury to eye and skin. Experimental Eye Research. 221: 109156 |
| Perry MR, Neal M, Hawks R, et al. (2021) A novel sulfur mustard (HD) vapor inhalation exposure model of pulmonary toxicity for the efficacy evaluation of candidate medical countermeasures. Inhalation Toxicology. 1-13 |
| Barker BS, Spampanato J, McCarren HS, et al. (2021) The K7 modulator, retigabine, is an efficacious antiseizure drug for delayed treatment of organophosphate-induced status epilepticus. Neuroscience |
| Beske PH, Wilhelm CM, Harvilchuck JA, et al. (2020) A Rodent Model of Sulfur Mustard Hematologic Toxicity for the Efficacy Evaluation of Candidate Medical Countermeasures. Military Medicine |
| Araj H, Tumminia SJ, Yeung DT. (2020) Ocular Surface - Merging Challenges and Opportunities. Translational Vision Science & Technology. 9: 3 |
| Yeung DT, Araj H, Harper JR, et al. (2020) Considerations in Developing Medical Countermeasures Against Chemical Ocular Toxicity. Toxicology Letters |
| Yeung DT, Harper JR, Platoff GE. (2020) The National Institutes of Health Chemical Countermeasures Research Program (NIH CCRP): A collaborative opportunity to develop effective and accessible chemical medical countermeasures for the American people. Drug Development Research |
| Yeung DT, Araj H, McNutt PM. (2020) Abstracts of Presentations from the 2020 Trans-Agency Scientific Meeting on Developing Medical Countermeasures to Treat the Acute and Chronic Effects of Ocular Chemical Toxicity, 25-26 February, Bethesda, Maryland. Toxicology Letters |
| Yeung DT, Harper JR, Platoff GE. (2020) Supporting Fundamental Chemical Toxicology Research To Inform Medical Countermeasure Developments: The National Institutes of Health Chemical Countermeasures Research Program. Chemical Research in Toxicology |
| Yeung DT, Bough KJ, Harper JR, et al. (2019) National Institutes of Health (NIH) Executive Meeting Summary: Developing Medical Countermeasures to Rescue Opioid-Induced Respiratory Depression (a Trans-Agency Scientific Meeting)-August 6/7, 2019. Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology |